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Abstract
Dendritic cells (DC) are a heterogeneous cell population that bridge the innate and adaptive immune systems. CD8a DC
play a prominent, and sometimes exclusive, role in driving amplification of CD8
+ T cells during a viral infection. Whether this
reliance on a single subset of DC also applies for CD4
+ T cell activation is unknown. We used a direct ex vivo antigen
presentation assay to probe the capacity of flow cytometrically purified DC populations to drive amplification of CD4
+ and
CD8
+ T cells following infection with influenza virus by different routes. This study examined the contributions of non-CD8a
DC populations in the amplification of CD8
+ and CD4
+ T cells in cutaneous and systemic influenza viral infections. We
confirmed that in vivo, effective immune responses for CD8
+ T cells are dominated by presentation of antigen by CD8a DC
but can involve non-CD8a DC. In contrast, CD4
+ T cell responses relied more heavily on the contributions of dermal DC
migrating from peripheral lymphoid tissues following cutaneous infection, and CD4 DC in the spleen after systemic
infection. CD4
+ T cell priming by DC subsets that is dependent upon the route of administration raises the possibility that
vaccination approaches could be tailored to prime helper T cell immunity.
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Introduction
Murine dendritic cells (DC) can be divided into at least six
different subsets [1]. Despite this heterogeneity, in previous studies
we have established that the tissue-derived CD8a
+ (CD8a) DC are
the main subset driving CD8
+ T cell amplification during the early
phase of the immune response [2–5].
In skin infection, migratory DC (such as Langerhans cells and
dermal DC) have long been thought to be key mediators of T cell
immunity. We have, however, recently shown that CD8
+ T cell
activation appears to be purely driven by CD8a DC [3–5]. This
suggests that the long held paradigm that coordinated maturation
and migration of peripheral DC to the lymph node is required for
T cell activation may be more complicated than first described. In
lung infection two distinct DC subtypes–the lymph node-resident
CD205
+CD11b
2CD8a
+ (CD8a) DC and the trafficking
CD205
+CD11b
2CD8a
2 DC–are responsible for activating naı ¨ve
virus-specific killer T cells [6]. Nevertheless, even in skin infection
with Herpes simplex virus-1 (HSV-1), which does not apparently
invoke migratory Langerhans cells directly for immune activation,
interplay between these DC transporting antigens and lymph
node-resident DC is key to triggering T cell amplification by cross-
presentation [6,7]. These findings suggest a more complex view of
viral antigen presentation than first thought. They allude to a
more likely scenario whereby co-operation between multiple
specialised DC is required to prime naı ¨ve T cells.
The role of different DC in major histocompatibility complex
(MHC) class II antigen presentation promoting CD4
+ T cell
priming in the setting of an infectious pathogen is poorly
understood. This is in part due to the paucity of in vivo models
that allow simultaneous analysis of the CD4
+ and CD8
+ T cell
responses to viral antigens. Despite this, a number of studies have
been undertaken to examine naı ¨ve CD4
+ T cell priming using
both model and infectious antigens. They have implicated the
involvement of CD11b
+ tissue-derived migratory DC in priming
CD4
+ T cell responses [8,9] [10]. Subcutaneous (s.c.) injection of
the MHC class II-restricted model antigen hen egg lysozyme
showed that both CD11c
+ CD8a DC and CD8a
2 (non-CD8a)
were capable of presenting hen egg lysozyme but CD8a DC were
most efficient [10]. By contrast, CD11b
+ DC, but not CD8a DC,
induced ovalbumin-specific CD4
+ T cell priming after s.c.
administration of soluble ovalbumin [9]. Itano and colleagues
[11] employed fluorescently-labelled protein to trace the role of
the skin-derived migratory DC in antigen presentation to CD4
+ T
cells. Significantly, Langerhans cells and dermal DC trafficked to
the draining lymph nodes on encounter with antigen and both
activated naı ¨ve T cells resulting in functionally effective CD4
+ T
cells. However, this group reported little involvement of CD8a DC
in priming CD4
+ T cells. Similarly in murine models of
Leishmaniasis, a parasitic infection whose control is mediated
mainly by CD4
+ T cells [12], antigen presentation appears to be
PLoS ONE | www.plosone.org 1 February 2008 | Volume 3 | Issue 2 | e1691restricted to CD8a DC [13] and CD11b
+DC, likely the dermal
DC [14]. These studies imply that tissue-derived trafficking DC
may play a more important role in activating CD4
+ T cells, but
they do not discount the involvement of CD8a DC.
In this report, we have endeavoured to understand the interplay
between different DC subsets in driving T cell activation following
subcutaneous and systemic infection with virus. This extends our
previous work by highlighting how major and minor DC subsets
are involved in both CD8
+ and CD4
+ T cell activation. We have
evaluated the contribution of tissue-derived trafficking DC, in
addition to the role of CD8a DC. We show that, although antigen
presentation to CD8
+ T cells is largely driven by the CD8a DC,
antigen presentation to CD4
+ T cells involved multiple DC
populations, highlighting the differential tasks of DC populations
in regulating immune responses.
Results
CD8a
+ DC dominate antigen presentation to CD8
+ T cells
during viral infection, while Langerhans cells and dermal
DC play minor roles in presentation
Subcutaneous inoculation with influenza WSN-gB virus resulted
in maximal expansion of endogenous glycoprotein B (gB)-specific
CD8
+ T cells at five days after infection in the popliteal lymph
nodes (Figure 1A) and seven days post-infection in the spleen
(Figure 1B). Such a priming approach gave an effective cytotoxic
T cell response when monitored by in vivo cytotoxicity thirty days
after infection indicating that memory T cells with cytotoxic
function are generated in this system (data not shown). The
recombinant influenza WSN-gB contains the HSV-1 glycoprotein
BC D 8
+ T cellepitope engineered into the neurominidasestalk.This
allowed us to take advantage of the gB-specific T cell receptor
transgenic as a tool to probe the antigen presenting capacity of
individual subsets of DC. To determine whether TCR transgenic
cells are amplified in vivo in a manner analogous to the endogenous
gB-specific CD8
+ T cells, we followed the expansion of gBT-I CD8
+
T cells after s.c. infection with WSN-gB. The expansion of TCR
transgenic cells in spleen appeared to peak two days earlier than for
endogenous virus-specific cells (Figure 1C). Similarly, the maximal
expansion of transgenic cells in the popliteal lymph nodes 72 h after
transfer occurred slightly earlier than that of endogenous gB-specific
T cells detectable by MHC tetrameric staining (Figure 1D), possibly
reflecting the initial high input precursor frequency of transgenic gB-
specific cells in the latter system.
Previously we have examined which DC populations drive
amplification of naı ¨ve CD8
+ T cells by direct ex vivo analysis
acutely after s.c. infection with influenza WSN-gB or HSV [4,5].
Although this is not a natural route of infection, it does reflect the
pathway of pathogen accidentally gaining access to the dermis
through injury to the protective barrier of the skin. We used this
route to determine whether our previous observation that skin DC
did not present HSV-1 viral antigens reflected a feature of the
HSV virus, or alternately, reflected a broader characteristic of
subcutaneous viral infection [3]. In this situation, we targeted the
peak of antigen presentation for analysis but it is not clear whether
the small window of antigen presentation examined reflected the
full spectrum of DC subpopulations involved in delivering
immunogenic signals driving amplification of T cells. To
determine how the functional expression of the surrogate influenza
epitope, SSIEFARL, derived from the glycoprotein B of HSV,
impacted on the level and duration of activation and expansion of
CD8
+ T cells, mice were infected s.c. with WSN-gB and at various
times after infection CFSE-labelled transgenic T cells specific for
the gB epitope were adoptively transferred. Three days after
transfer, popliteal lymph nodes and spleen cells were harvested to
examine proliferation of transgenic T cells by flow cytometry
(Figure 1C,D,E). The results indicated that maximal antigen
presentation occurred in the popliteal lymph nodes two days after
infection and decreased over the next four days.
In earlier studies which suggested that CD8a DC were the sole
DC subset responsible for presentation of influenza antigen,
analysis of antigen presentation was restricted to segregation of
DC populations into CD8a DC, CD8a
2 DC (termed double-
negative (DN) DC) and plasmacytoid DC (pDC) (Figure 2A, 3A,B)
[4]. As DN DC are composed of multiple DC subsets including
CD205
2CD11b
+, Langerhans cells and dermal DC (Figure 2B),
we questioned whether weak presentation by individual subsets
might have been overlooked. To examine more closely whether
the migratory subsets of DC could be involved in the presentation
of antigen to CD8
+ T cells, particularly later in infection when
Langerhans cells may have had an opportunity to migrate to the
draining lymph nodes [15], we extended our analysis to include
these DC subsets at 48 and 72 h after infection (Figure 3C,D). DC
were sorted in two ways: either as previously into (i) CD8a DC,
DN DC and pDC or (ii) Langerhans cells (CD11c
+CD205
high),
dermal DC (CD11c
+ CD8a
low/– CD205
intermediate), CD8a DC
(CD11c
+ CD8a
+ CD205
intermediate) and DN DC (CD11c
+CD8a
–
CD205
–) (Figure 2A,B). Building on previous findings using the
three-way subdivision of DC (Figure 3A,B), CD8a DC were found
to be the dominant APC. When pDC were excluded and DC were
additionally separated into conventional subsets, however, weak,
but reproducible responses were seen for Langerhans and dermal
DC (Figure 3C,D). This suggested that while CD8a DC
predominate in viral antigen presentation, other DC subsets may
contribute to the development of the immune response.
Tissue-derived DC dominate activation of naı ¨ve CD4
+ T
cell following subcutaneous influenza infection
Given that Langerhans cells and dermal DC do not appear to
play a major role in activating CD8
+ T cells during s.c. infection,
we hypothesised that these subsets may be more important in
driving activation of CD4
+ T cells. To extend our observations
into a system that would enable us to simultaneously investigate
the contribution of antigen presentation by different DC subsets to
both CD4
+ and CD8
+ T cells, we utilized influenza infection in
BALB/c mice. In this model, we were able to take advantage of
the MHC class II and MHC class I-restricted T cell receptor
transgenic mice that recognize antigenic determinants encoded in
influenza haemaglutinin (HA). This allowed us to simultaneously
track the response of both CD4
+ and CD8
+ T cells to the same
viral antigen. Firstly, we determined the in vivo kinetics of antigen
presentation driving expansion of HA-specific CD8
+ (CL4) and
CD4
+ (HNT) T cell responses (Figure 4A,B). The pattern of T cell
activation was similar to that observed for s.c. infection with WSN-
gB infection in C57BL/6 mice with strong proliferation observed
for CD4
+ and CD8
+ T cells peaking around days two and three.
To examine antigen presentation by different DC subsets in
response to PR8 virus, BALB/c mice were inoculated by s.c.
infection and popliteal lymph nodes were harvested two or three
days later for DC purification. In the first set of experiments, DC
were separated on the basis of CD11c, CD8a and CD45RA
expression into CD8a DC, pDC (CD11c
+CD45RA
+CD8a
2 DC)
and DN DC and examined for their capacity to present MHC
class I and II antigens at both 48 (Figure 5A,B) and 72 h
(Figure 5C,D) after infection. This initial separation strategy was
used primarily to examine presentation by pDC and CD8a DC
(Figure 2A). This revealed that CD8a DC were the major
population responsible for both MHC class I and II presentation,
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negligible responses were seen for DN DC (containing migratory
DC) their capacity to stimulate naı ¨ve virus-specific T cells could
not be excluded based on earlier findings in the C57BL/6 system
(Figure 3). To better examine the capacity of migratory DC to
present viral antigen in this model, DC were depleted of pDC and
separated into the four conventional subsets examined earlier
(Figure 6). As in Figure 2B, conventional DC were separated into
CD8a DC, Langerhans cells, dermal DC and those DC not
expressing either CD8 or CD205 (now referred to as DN DC)
(Figure 6A–D). Strikingly, this form of separation revealed a major
role for dermal DC in both MHC class I and MHC class II
priming in BALB/c mice. This is in contrast to the relative
absence of antigen presentation detected by DN DC when the
unfractionated population was analysed (Figure 5A,B). This
approach highlights the importance of fine dissection of DC
subsets, particularly when broad phenotypic separation is used in
the first instance.
Figure 1. In vivo expansion of endogenous and transgenic glycoprotein B-specific CD8
+ T cells following footpad infection with
recombinant influenza WSN-gB. Endogenous gB-specific CD8
+ T cells were tracked by staining with gB498–505 MHC class I tetramers conjugated
to the fluorescent dye, phycoerythrin. A, The number of gB-specific CD8
+ T cells were analysed in the popliteal lymph node and B, spleen five, seven
and ten days after s.c. infection via footpad injection with 400 PFU of recombinant influenza, WSN-gB. Data are pooled from two independent
experiments and show the mean of four to six mice at each time point. C,5 610
4 Ly5.1 gBT-I-specific T cells were adoptively transferred by tail vein
injection into naı ¨ve C57BL/6 mice one day prior to s.c. infection with 400 PFU of recombinant influenza, WSN-gB. Five and seven days after infection,
the number of Ly5.1 gBT-I cells in the spleen was enumerated by flow cytometry by staining for surface expression of CD8a and CD45.1. Data are
pooled from two independent experiments and show the mean6SEM of eight to twelve mice at each time point. D, Influenza viral antigen stimulates
naı ¨ve gBT-I CD8
+ T cells for several days after infection. 2610
6 purified CFSE-labelled Ly5.1gBT-I CD8
+ T cells were adoptively transferred into naı ¨ve
C57BL/6 mice at various times after s.c. footpad infection with influenza WSN-gB. Proliferation of transferred Ly5.1gBT-I CD8
+ T cells was assessed in
the draining popliteal lymph node 72 h after transfer by evaluating loss of CFSE fluorescence. Data are pooled from two independent experiments
and show the mean6SEM. The number of mice examined at each time point are indicated by n. E. Naı ¨ve CFSE-labelled gBT-I CD8
+ T cells were
transferred into mice infected subcutaneously one to six days earlier with WSN-gB. T cell proliferation in the popliteal lymph node was analysed by
flow cytometry three days after transfer. The percentage of proliferated cells is shown in the upper left hand corner of each graph. Profiles show
representative CFSE proliferation from data shown in D.
doi:10.1371/journal.pone.0001691.g001
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multiple DC subsets to CD4
+ T cells is maintained
following intravenous infection
In earlier studies, we used the three-way pDC sort to identify the
CD8a DC as the primary subset involved in amplifying CD8
+ T
cell responses to influenza WSN-gB after i.v. infection [4]. To
determine whether a similar skewing of DC capacity to prime
CD8
+ T cell responses extended to other influenza viruses and to
explore whether this was also the case for CD4
+ T cells we
analysed the ability of pDC, CD8 DC and DN DC to prime
influenza-specific MHC class I (CL4) and class II (HNT) in mice
infected by intravenous (i.v.) inoculation two days previously with
influenza PR8. This approach showed that although CD8 DC were
the major DC presenting antigens to CD8
+ T cells (Figure 7A),
multiple subsets of DC, namely the CD8 DC and DN DC presented
MHCclassIIantigensequallyefficientlytoCD4
+Tcells(Figure7B).
This strong antigen presenting ability of DN DC, which consists of
more than one DC subset, prompted us to further subdivide this
population into its respective subsets. The DC from mice infected
with PR8 i.v. were depleted of pDC and separated into
CD8a
+CD4
2,C D 8 a
2CD4
+ and CD8a
2CD4
2 DC (Figure 2C)
and cocultured with HA-specific CD4
+ or CD8
+ Tc e l l s .T h i s
confirmed that CD8a DC were the sole DC subset responsible for
presenting viral antigens to naı ¨ve CD8
+ T cells, but importantly
revealed that CD4 DC, and to a lesser extent, DN DC were also
involved in driving activation of CD4
+ T cells (Figure 7C,D).
These data show that after i.v. infection, viral antigen
presentation to CD8
+ T cells is effected primarily by the CD8a
DC while MHC class II antigen presentation needed to ensure
activation of CD4
+ T cells, is performed by multiple DC subsets.
Discussion
The signals and interactions that drive effective DC priming of T
cells resulting in protective immunity remain mostly undefined.
Although much research has focused on the dual capacity of CD8a
DC to promote the induction of tolerance and immunity to
pathogens through amplification of CD8
+ T cells, it remains unclear
to what extent MHC class II presentation by CD8a DC is important
for the amplification of CD4
+ T cells in viral infections [3,5,16,17].
DC possess highly effective mechanisms to capture, transport
and process antigens. This allows them to present either
endogenous viral antigens synthesised within the cell or exogenous
antigens captured from other infected cells. In vitro, all DC subsets
tested can present viral antigens, such as influenza or HSV
antigens [4]. In contrast, in vivo, CD8a DC resident within the
lymphoid tissues appear to be almost solely responsible for driving
the activation of CD8
+ T cells [2–5]. Such a universal restriction of
both MHC class I and II antigen presentation to a single DC
subset in pathogen infection is likely to significantly limit the
capacity to activate lymphocyte populations. Many viruses have
mechanisms that interfere with antigen presentation pathways and
infection of DC offers an opportunity to exploit such mechanisms
to promote survival of the virus by substantially crippling the
immune response itself. Such a targeting strategy is utilized by
lymphocytic choriomeningitis virus (LCMV, clone 13) to selec-
tively infect CD205
+ DC through the a-dystroglycan receptor,
effectively disabling any capacity to generate cytotoxic T cells
[18,19]. To circumvent such a situation, it is likely that other DC
subsets are conscripted to activate CD4
+ T cells, and possibly B
cells, during an immune response to pathogens. This has provoked
our detailed assessment of the role of different subsets of DC in
activating CD4
+ and CD8
+ T cells in viral infections.
Cutaneous immune function requires skin-derived antigen
presenting cells, such as Langerhans cells and dermal DC, to
convey antigenic signals from the periphery and activate CD8
+ T
cells. Several recent studies of viral infections have challenged this
paradigm suggesting that lymph node-resident DC, namely the
CD8a DC, and not Langerhans cells, drive amplification of CD8
+
T cell responses, while non-CD8a DC have been purported to
play a dominant role in transporting antigen to the lymph node
rather than direct priming of T cells [2,3,5]. This was based on the
Figure 2. DC were isolated from the popliteal lymph node or
spleen of mice and flow cytometrically purified into DC subsets
according to one of three sorting protocols. A. In the first
approach, CD11c
+ cells were sorted from the popliteal lymph node or
spleen into CD8a
+ (CD8a) DC, CD8a
+/2CD45RA
+ plasmacytoid DC (pDC)
and CD8a
2CD45RA
2 double negative (DN) DC. B. In the second
approach, CD11c
+ cells from popliteal lymph node were further
dissected into CD8
2CD205
high Langerhans cells, CD8a
2CD205
int dermal
DC, CD8a
2CD205
2 DN DC and CD8a
+CD205
int DC. C. In the third
approach, CD11c
+ cells were sorted from light density cells isolated
from spleen into CD8a
+CD4
2, CD8a
2CD4
+ and CD8a
2CD4
2 DC.
doi:10.1371/journal.pone.0001691.g002
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cutaneous HSV infection [3]. However, intranasal infection with
influenza virus or HSV-1 results in both CD11b
2 and CD8a DC
effectively presenting viral antigens to CD8
+ T cells [6]. Similarly,
lentiviruses, appear to readily infect skin-derived DC and retain
their capacity to present viral antigens after trafficking suggesting
that both the virus and the antigen influence antigen presentation
by different DC subsets [2,6,20].
Recent studies addressing the identity of the DC population(s)
responsible for initiating CD4
+ T cell immune responses against
pathogens have generally supported a predominant role for non-
CD8a DC with only scant evidence for CD8a DC involvement
[8,13,14,21]. For example, immunity to Leishmania infection is
largely driven by antigen presentation of the Leishmania analogue
of the receptors of activated C kinase, known as LACK, antigen by
a tissue-derived CD11b
+ DC that was present in the draining
lymph node as early as 2 days after infection [13]. The
involvement of CD11b
+ cells in responses against Leishmania
was confirmed by Lemos et al. [14] in a study that however also
provided evidence of involvement of the CD8a DC. More
recently, Leon et al. [21], showed that in situ differentiation of
CD11b
+ monocyte-derived DC driven by inflammatory mediators
could control the induction of protective responses to L. major.
Similar to Leishmania infection, analysis of herpes simplex virus
type 2 (HSV-2) infection of the vagina revealed dermal DC as the
major antigen-presenting population activating CD4
+ T cells in
the draining lymph node [8]. These studies give the impression
that MHC class II antigen presentation to CD4
+ T cells might be
largely restricted to non-CD8a DC. In infection with Toxaplasma
gondii, CD8a DC play a clearly established role in MHC class II
presentation [22]. In this case, the capture of the immunodomi-
nant antigen of the parasite, profilin, is augmented by TLR 11
expression on CD8a DC. Antigen presentation by dermal DC
directly to CD8
+ T cells has not been obvious in several infectious
settings. However, in our examination of s.c. WSN-gB infection in
C57BL/6 mice, careful separation of DC into Langerhans cells
and dermal DC revealed only a small population of non-CD8a
DC that could be important in the immune response.
Discrepancies between reports have been noted in analysing the
specific role of different DC populations in viral, bacterial or
parasitic infections [3,5,8,13,14,23]. These differences could arise
in part from differences between the experimental models
employed, or could alternately, be attributable to differences in
the efficiency with which different DC subsets present on MHC
class I and class II molecules [24–28]. To exclude such variables
from our system and to expand our analysis of the contribution of
different DC subsets to viral infection, we took advantage of the
availability of HA-specific CD4
+ and CD8
+ T cells to probe
antigen presentation in influenza virus in BALB/c mice in vivo.
This approach allowed us to examine the ability of different DC
subsets to activate both CD4
+ and CD8
+ T cells responding to the
same viral protein. In our studies we clearly showed that both
CD8a and non-CD8a DC play a central role in presenting MHC
class I and II antigens to T cells in generating immunity.
Previous studies of DC antigen presentation in the viral setting
have suggested a generalized dichotomy in which CD8a and non-
Figure 3. CD8a DC dominate antigen presentation to naı ¨ve gBT-I CD8
+ T cells following s.c. infection. C57BL/6 mice were infected with
WSN-gB by s.c. injection into the footpad. 48 and 72 h after infection, the popliteal lymph node were isolated and non-DC lineages were removed by
antibody depletion. A,B. CD11c
+ DC subsets were purified by flow cytometric sorting into DN DC, CD8a DC and pDC before culturing titrating
numbers of each subset with 5610
4 CFSE-labelled gBT-I CD8
+ T cells. Proliferation was analysed at 60 h of culture. Data show the mean and SEM of
three independent experiments. C,D. Lymph node-resident CD8a DC and not skin-derived trafficking DC, prime naı ¨ve CD8
+ T cells following s.c.
infection with WSN-gB. C57BL/6 mice were infected with 400 PFU by s.c. injection into the footpad. At 48 h (C) and 72 h (D) following infection, DC
were enriched from popliteal lymph node and flow cytometrically sorted into Langerhans cells (CD205
+CD8a
+/2), dermal DC (CD205
intCD8a
2), CD8a
DC (CD205
+CD8a
+) or DN DC (CD205
2CD8a
2). Titrating numbers of purified DC subsets were cocultured with 5610
4 CFSE-labelled gBT-I CD8
+ T cells.
The x-axis shows the range of DC used as stimulators over different experiments. Proliferation was analysed at 60 hr of culture. Data are pooled from
three independent experiments and show the mean and SEM. Significant differences (p#0.05) in T cell proliferation induced by different DC
populations are indicated by an asterisk.
doi:10.1371/journal.pone.0001691.g003
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presentation, respectively. Our study provides the first direct
assessment of MHC class I and class II antigen presentation to the
same protein in a viral system that we know of to date. In earlier
work, we showed that priming of virus-specific cytotoxic T cells
depended on presentation of cognate antigens on MHC class I and
II molecules by the same DC implying that CD8a DC, at least, are
also involved in ensuring effective CD4
+ T cell responses [5]. It is
now clear that a broader array of DC types within the DC network
can effectively present to CD4
+ T cells. Within the lymphoid
tissues, non-CD8a DC have been shown to be most efficient at
presenting exogenous antigens on MHC II molecules, while CD8a
DC are highly efficient at presenting exogenous antigens on MHC
I molecules [27,29]. Recently, Dudziak et al. [29] elegantly
demonstrated that the preferential association of CD8a and non-
CD8a DC subsets with priming of CD8
+ and CD4
+ T cells to the
model antigen ovalbumin reflected the differential expression of
genes important for MHC class I and II antigen processing and
presentation pathways between the DC populations. This suggests
that DC subsets possess intrinsic properties that allow them to
handle exogenous antigens selectively for presentation to T cells.
However, all DC subsets appear to be able to present
endogenously synthesized viral antigens such as from influenza
or HSV infection [4,30,31]. During influenza infection in vivo,
however, two subsets of DC predominantly present viral antigens
raising the possibility that non-CD8a DC, such as the migratory
ones, are more easily accessed by infecting virus. Importantly,
these DC can present antigens on MHC class II, and MHC class I
molecules, but in addition, they may transport viral antigens to
lymphoid-tissue resident CD8a DC, that are specialized to take up
exogenous antigens and preferentially present these antigens to
CD8
+ T cells. This capacity to differentially present antigens by
different DC may be important in promoting effective naı ¨ve and
memory T cell responses [32].
Collectively, our results suggest that although CD8a DC are a
key DC population involved in priming CD8
+ T cell responses,
targeting of both CD8a and non-CD8a DC subsets may be
required to ensure effective long lasting protective immunity.
Figure 4. Highly efficient antigen presentation to CD4
+ and CD8
+ T cells is limited to the early phase of infection following s.c. viral
infection. 2610
6 CFSE-labelled purified CD4
+ and CD8
+ T cells specific for the HA epitopes of influenza were adoptively transferred into naı ¨ve BALB/
c mice infected on days 1 to 5 respectively with PR8 influenza virus. Proliferation of T cells in the popliteal lymph node was indicated by dilution of
the CFSE stain 3 days after transfer. A. Data show representative flow cytometric profiles of T cell proliferation from popliteal lymph node from one of
two similar experiments and B, Histogram shows the mean number of dividing T cells in popliteal lymph node6SEM 3 days after transfer. Data are
pooled from two experiments showing 5 mice for HNT CD4
+ expansion and 6 mice for CL4 CD8
+ expansion.
doi:10.1371/journal.pone.0001691.g004
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the footpad. The popliteal lymph nodes were isolated and non-DC lineages were removed by antibody depletion. CD11c
+ DC subsets were purified
by flow cytometric sorting into DN DC, CD8a DC and pDC before culturing titrating numbers of each subset with 5610
4 CFSE-labelled influenza-
specific CD8
+ T cells (A,C) or CD4
+ T cells (B,D)4 8( A,B) and 72 (C,D) h after infection. The x-axis shows the range of DC used as stimulators over
different experiments. Proliferation was analysed at 60 h of culture. Data are pooled from (A–C) three and four (D) independent experiments and
show the mean and SEM. Significant differences (p#0.05) in proliferation induced by different DC populations are indicated by an asterisk.
doi:10.1371/journal.pone.0001691.g005
Figure 6. Lymph node-resident and tissue-derived trafficking DC prime naı ¨ve influenza HA-specific CD8
+ and CD4
+ T cells following
s.c. infection with influenza PR8. Naı ¨ve BALB/c mice infected with influenza virus (PR8) by s.c. injection. 48 (A,B)o r7 2h( C,D) after infection, DC
were enriched from the popliteal lymph nodes and flow cytometrically purified into Langerhans cells (CD11c
+ CD205
+), dermal DC (CD11c
+ CD205
int),
CD8a (CD11c
+ CD8
+) DC or DN (CD11c
+CD8
2CD205
2) before culturing titrating numbers of purified DC with 5610
4 CFSE-labelled CD8
+ (CL4) or CD4
+
(HNT) T cells specific for the HA epitopes of influenza. The x-axis shows the range of DC used as stimulators over different experiments (A,B) or the
number of DC (C,D) used in each well. Proliferation was analysed at 60 hr of culture. Data represent the mean6SEM of four (A,B) and three (C,D)
independent experiments.
doi:10.1371/journal.pone.0001691.g006
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Mice
C57BL/6 (B6) (H-2
b), BALB/c (H-2
d), gBT-I (H-2K
b-restricted
glycoprotein B, gB498–505) [33], CL4 (H-2K
d-restricted anti-
influenza hemagglutinin, HA512–520) [34] and HNT (IA
d-restricted
anti-HA126–138) [35] mice were bred and maintained in specific
pathogen-free conditions at the animal facilities of the Walter and
Eliza Hall Institute of Medical Research (Melbourne, Australia).
Experiments with all mice began when mice were six to ten weeks
of age and were performed in accordance with guidelines of the
Melbourne Directorate Animal Ethics Committee.
Virus Infections
Mice were anaesthetized with methoxyfluorane and then
infected with influenza virus diluted in 20 ml of PBS for footpad
infection. For footpad infection either 10
2.6 PFU recombinant
influenza WSN-gB (H1N1) which contains the gB498–505 K
b-
restricted epitope of HSV inserted into the neurominidase stalk
[36] was used, or 10
3.9 A/Puerto Rico/8/34 (Mt. Sinai, H1N1)
(PR8) influenza A virus was used. For i.v. infection 10
4.9 PR8 virus
was diluted in 200 ml of PBS and injected into the tail vein.
Preparation of CFSE-labelled transgenic T cells
Peripheral lymph nodes (inguinal, axillary, brachial, sacral,
superficial cervical and mesenteric) were obtained from CD4
+
(HNT) mice or CD8
+ (CL4 or gBT-I.1) TCR transgenic mice and
purified using a cocktail of optimally titred antibodies to deplete
cells expressing Mac-1 (M1/70), Mac-3 (F4/80), Ter-119, GR1
(RB6-8C5), MHC class II (M5/114) and either CD8 (53.6.7) or
CD4 (GK1.5) followed by sheep anti-mouse and anti-rat
dynabeads (Dynal). Enriched cells contained 87–96% specific
TCR transgenic T cells. These were labelled with 5,6-carboxy-
fluorescein diacetate succinimidyl ester (CFSE; Molecular Probes)
by incubating 10
7 purified cells per ml with 5 mM CFSE for
10 min at 37uC. Cells were then washed three times in hepes
modified Eagles medium containing 2.5% FCS (HEM2.5).
Analysis of virus-specific CD8
+ T cell numbers by PE-
streptavidin conjugated K
b-gB tetramer
To quantify the number of viral antigen-specific T cells, single
cell suspensions from spleen and lymph nodes were firstly enriched
for CD8
+ T cells using magnetic bead depletion with the
antibodies M1/70 (anti-Mac-1), F4/80, Ter 119, RB6-8C5 (anti-
Gr-1), M5/114 (anti-class II MHC) and GK 1.5 (anti-CD4)
followed by goat anti-rat IgG-coupled magnetic beads (Dynal,
Oslo and Qiagen).
Enriched CD8
+ cells were washed and stained with PE-
streptavidin conjugated K
b-gB tetramer containing the immuno-
dominant HSV gB498–505 peptide for 45 minutes at room
temperature. Cells were then stained with APC conjugated
anti-CD8 mAb (53-6.7) for 30 minutes on ice in a balanced
salt solution containing 2% FBS. PI staining was used to
exclude dead cells (2 mg/mL; Sigma) and data was acquired on
at least 10
4 viable cells using a FACSCalibre flow cytometer (BD
Biosciences). Data was analysed using CellQuest Pro (BD
Biosciences).
Figure 7. Dendritic cell subsets mediating MHC class I and class II-restricted antigen presentation differ following intravenous
infection. A,B, 24 h after infection with PR8 virus, non-DC were depleted from spleens and the remaining cells were purified by flow cytometry into
CD8a DC (CD8a
+CD45RA
2), CD4 DC (CD4
+CD45RA
2), and pDC (CD8a
2CD4
2CD45RA
2); or C,D alternately, CD8a DC (CD8a
+CD4
2), CD4 DC
(CD8a
2CD4
+) or DN DC (CD8a
2CD4
2) subsets. Titrating numbers of each subset was cocultured with 5610
4 CFSE-labelled HA-specific CD8
+ or CD4
+
T cells and the amount of proliferation was measured at 60 h of culture by the loss of CFSE fluorescence. Data show the mean6SEM of three (A,C) to
four (B,D) independent experiments. Significant differences (p#0.05) in proliferation induced by different DC populations are indicated by an asterisk.
doi:10.1371/journal.pone.0001691.g007
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DCs were isolated essentially as described [15,37]. Briefly, the
draining lymph nodes or spleen fragments were digested for
20 min at room temperature with collagenase/DNase (1 mg/ml
collagenase type II, Worthington Biochemicals, Lakewood, NJ;
and 1 mg/ml grade II bovine pancreatic DNase I, Boehringer-
Mannheim, Mannheim, Germany) and then treated for 5 min
with EDTA to disrupt T cell-DC complexes. Cells not of the DC
lineage were depleted by incubating in predetermined optimal
concentrations of purified Abs: anti-CD3 (KT3), anti-Thy1 (T24/
31.7), anti-CD19 (ID3), anti-GR-1 (RB6-8C5), and anti-erythro-
cyte (TER-119) and then removing the Ab-binding cells with anti-
rat Ig-coupled magnetic beads (Dynabeads; Dynal, Oslo, Norway).
Note that in our hands pDC are not depleted using anti-GR-1
mAb (19, 20). The DCs in the enriched populations were gated as
CD11c
+ cells before sorting into specific subsets by fluorescence
activated cell sorting (MoFlo instrument; Cytomation, Fort
Collins, CO). For lymph node, DC were sorted into CD8a
+,
CD45RA
+ and DN DC or alternatively, CD8a
low/2CD205
high
(Langerhans cells), CD8a
highCD205
2 (conventional CD8a
+ DC),
CD8a
2CD205
int (dermal DC) and CD CD8a
2CD205
2 (DN
DC). In our hands staining pDC with CD45RA faithfully
recapitulates staining with more recently developed antibodies
such as pPDCA-1, therefore CD45RA was used to maintain
consistency with previous studies. Post-sorting analysis of sorted
DC populations showed that purity ranged from 90–99% and the
average purity of populations used for stimulation were 98%.
Analysis of in vitro proliferation of naı ¨ve T cells by DC
5610
4 enriched CFSE-labelled CD4
+ or CD8
+ TCR transgenic
cells were added to graded numbers of flow cytometrically sorted
DC in 200 ml RPMI 1640 containing 10% FCS, 50 mM2 -
mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin in 96-well V-bottom plates (CostarH,
Corning Incorporated, NY). Cultures were analysed for prolifer-
ation after 60 hr. Cells were harvested and stained with anti-CD4-
APC or anti-CD8a-APC (GK1.5, 53-6.7; BD Pharmingen) and
resuspended in 150 ml flow cytometry buffer containing 2.5610
4
Callibrite beads (6 mm; Becton Dickinson). Samples were analysed
by flow cytometry by on PI
2 exclusion until 5610
3–1610
4 beads
were collected. Differences in proliferation induced by different
subsets of DC were analysed using the Student’s t-test. Statistically
significant comparisons, p#0.05, are denoted with an asterisk.
Analysis of antigen presentation in vivo
Mice inoculated with influenza virus or left untreated and
2610
6 CFSE-labelled transgenic cells were adoptively transferred
into recipients by i.v. injection. Then, 60–72 h later, mice were
killed and gBT-I, HNT or CL4 proliferation in popliteal lymph
node or spleen was determined by flow cytometry.
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